Navigation Links
AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis

that this first AP study for ulcerative colitis revealed our treatment to be clinically active, despite the short seven day treatment period and the severity of the patients' disease. These results are very promising for the future development of AP for ulcerative colitis, where we plan to administer AP treatment for longer periods. Also importantly, results from this trial revealed that the treatment is very well tolerated. This is potentially good news for ulcerative colitis sufferers, who are looking for safe and effective treatment options."

AM-Pharma will continue to study the oral use of AP for ulcerative colitis in a further Phase II clinical study. Once safety and efficacy have been confirmed in a larger group of patients, AM-Pharma intends to license the product to a partner who will take on the late-stage development and worldwide commercialisation of AP.

Notes to editors:

About AM-Pharma www.am-pharma.com AM-Pharma is a biopharmaceutical company focused on the preclinical and clinical development of novel compounds in the field of severe infectious diseases and inflammatory diseases. All its products are based on endogenous molecules which have been optimised to combat disease.

AM-Pharma is currently conducting Phase II clinical trials for two products; Alkaline Phosphatase for sepsis, acute renal failure and ulcerative colitis; and Anti-microbial Peptide hLF1-11 for the prevention of infections in hemopoietic stem cell transplant patients.

AM-Pharma is based in Bunnik, The Netherlands with a staff of 20. The company is financed by, amongst others, Forbion Capital Partners, Inventages Venture Capital and Theratase plc. Once product safety and efficacy have been established, AM-Pharma will look for world-wide development and marketing partners for its products.

About Alkaline Phosphatase (AP)

The endogenous enzyme Alkaline Phosphatase is expr
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial with Alkaline Phosphatase in Acute Renal Failure
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:9/17/2014)... and SAN JOSE, Calif. , Sept. 17, ... named as a laureate of The Tech Awards 2014, ... to benefit humanity and spark global change. The Tech Awards, ... presented by Applied Materials, Inc., selected Gradian as one of ... Photo - http://photos.prnewswire.com/prnh/20140917/146680 Gradian equips ...
(Date:9/17/2014)... India , September 17, 2014 ... antagonist, GRC 17536, has shown positive data in a ... painful diabetic neuropathy , Glenmark ... Receptor Potential Ankyrin 1 (TRPA1) antagonist, GRC 17536 has ... placebo controlled, multi-centre, proof of concept study conducted on ...
(Date:9/17/2014)... YORK , Sept. 17, 2014  Millions of people ... cervical disc disease. Recently the FDA approved ... cervical disc, an innovative implant device developed by Spinal Kinetics, ... resulting in neck and or arm pain. Hospital for Special ... is the only hospital in New York City ...
Breaking Medicine Technology:Gradian Health Systems Named A 2014 Laureate of The Tech Awards 2Gradian Health Systems Named A 2014 Laureate of The Tech Awards 3Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 2Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 3Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery 2
... SweetSpot Diabetes Care, Inc. announced today it has ... Drug Administration (FDA) for the SweetSpot Diabetes Data Management ... understand and use blood glucose meter data to diagnose ... many patients and health care providers to develop this ...
... , Inc. (OTC: HEWA), a leading VIPPS-accredited, ... pre-order program to enable consumers immediate access to Atorvastatin ( ... the medication at up to 50 percent less than ... "We will be one of the earliest and most ...
Cached Medicine Technology:SweetSpot Diabetes Care Receives FDA 510(k) Clearance for SweetSpot Diabetes Data Management Service 2HealthWarehouse.com Offers Lowest Price Generic Lipitor on the Market 2HealthWarehouse.com Offers Lowest Price Generic Lipitor on the Market 3
(Date:9/17/2014)... Dennis Thompson ... News) -- Twelve states now have confirmed cases of ... sickened hundreds of children, U.S. health officials report. ... New York, Oklahoma and Pennsylvania collectively have 130 laboratory-confirmed ... for Disease Control and Prevention. The virus, part ...
(Date:9/17/2014)... Rochelle, NY, September 17, 2014Diffusion Tensor Imaging (DTI), ... detects microstructural changes in brain tissue, can help ... outcomes following mild traumatic brain injury compared to ... according to a new study published in ... Mary Ann Liebert, Inc., publishers . The ...
(Date:9/17/2014)... out of the molecular therapeutic laboratory directed by Richard ... Women,s Oncology. Entitled "HE4 expression is associated with hormonal ... was recently published in the international science journal ... goal of the study was to investigate the role ... response to hormones and hormonal therapies. HE4 is a ...
(Date:9/17/2014)... 2014 For over a year now, ... data logging products to industries in Greece specializing in ... development of management systems for certification and accreditation. Main ... technical support. , MadgeTech Inc. is excited as ... are very pleased to see the success of Main ...
(Date:9/17/2014)... This news release is available in Spanish . ... overweight affect more than half of the population in ... organism, one of which affects liver function. Fat accumulates ... circumstances, causes inflammation, fibrosis and finally, cirrhosis. To date, ... been hepatic biopsy. Imaging techniques such as abdominal ecography ...
Breaking Medicine News(10 mins):Health News:12 States Now Reporting Severe Respiratory Illness That Targets Kids 2Health News:12 States Now Reporting Severe Respiratory Illness That Targets Kids 3Health News:New MRI technique helps clinicians better predict outcomes following mild traumatic brain injury 2Health News:Researchers examine role of hormone in response to ovarian cancer treatment 2Health News:Main Solutions Now Distributing MadgeTech Data Loggers in Bulgaria 2Health News:Magnetic resonance helps to detect and quantify fat in liver 2
... , Leading U.S. online ... competitors , , CINCINNATI, July ... today announced that it will offer a 30-day supply of over ... prices below that of competitors, including Wal-Mart and Target, HealthWarehouse.com is ...
... RICHMOND, Va., July 13 Long term care costs in ... significant financial pressure on those in or near retirement. As ... offers a suite of insurance products to help people proactively ... Virginia can take advantage of a new program designed to ...
... , TAMPA, Fla., July 13 ... & Cosmetic Center of Tampa Bay has selected Artefill, the first ... lines, to treat patients who are looking for a longer lasting ... past several years due to its proven success and effectiveness for ...
... , DALLAS, July 13 As Americans hit the ... Gym, the world,s leading authority on health and fitness, is exposing some ... must have nutrition and fitness facts to help everyone reach their individual ... of running on a treadmill versus running outside, the fitness experts at ...
... relationships between children and their parent of the same gender ... to understanding why some young people become obese and others ... has shown. A study published today in the ... mothers are classified as clinically obese are significantly more likely ...
... Long term care costs in Colorado continue to rise at ... in or near retirement. As a leader in the long ... products to help people proactively plan for their future. Now, ... a new program designed to simplify the process of purchasing ...
Cached Medicine News:Health News:HealthWarehouse.com Announces $3.50 Prescription Drug Program 2Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 2Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 3Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 4Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 5Health News:Vein & Cosmetic Center of Tampa Bay Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 2Health News:Vein & Cosmetic Center of Tampa Bay Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 3Health News:Gold's Gym Debunks America's Most Common Fitness Myths 2Health News:Gold's Gym Debunks America's Most Common Fitness Myths 3Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Colorado AARP Members 2Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Colorado AARP Members 3Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Colorado AARP Members 4Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Colorado AARP Members 5
... immunoassay(EIA) test system for the detecton ... Sm, RNP, SSA, SSB, Scl-70 and ... from this assay can be used ... of autoimmune disease. This product is ...
... Multiparameter Kit is designed for ... of the most common autoantibodies. ... quality control system. The built-in ... in each strip gives the ...
... were designed with the proper sensitivity and ... diagnosis of autoimmune disease. Sera from over ... normal individuals were tested during the development ... Concepts compared the results to reference methods ...
... The assay uses highly pure, functional human C1q ... complexes (CIC). In the first stage, CIC in ... controls and standards are dispensed into the C1q ... removed in a washing step and a ready ...
Medicine Products: